| Literature DB >> 30223884 |
Oleksandr Butskiy1,2, Brent A Chang3, Kimberly Luu3, Robert M McKenzie3, Donald W Anderson3.
Abstract
BACKGROUND: To describe and evaluate a four step systematic approach to dissecting the recurrent laryngeal nerve (RLN) starting at the cricothyroid junction during thyroid surgery (subsequently referred to as the retrograde medial approach).Entities:
Keywords: Recurrent laryngeal nerve; Retrograde dissection; Surgical anatomy; Surgical technique; Thyroidectomy
Mesh:
Year: 2018 PMID: 30223884 PMCID: PMC6142389 DOI: 10.1186/s40463-018-0306-7
Source DB: PubMed Journal: J Otolaryngol Head Neck Surg ISSN: 1916-0208
Fig. 1Illustration to Theodor Kocher’s 1895 surgical textbook demonstrating the dissection in the tracheo-esophageal groove after the thyroid is swept medially [4]
Fig. 2Subtotal division of Berry’s suspensory ligaments and exposure of the cricothyroid region. a Schematic demonstrating anatomy and instrument orientation; b Subtotal division of Berry’s ligaments; c Placing Berry’s ligament remnant on the stretch with avascular space open
Fig. 3Identification and dissection of the recurrent laryngeal nerve (RLN). a RLN path deep to the Berry’s ligament remnant; b Berry’s ligament remnant dissected to reveal the RLN and the terminal branch of the inferior thyroid artery (nerve is placed on retraction to demonstrate anatomy to the photographer); c Thyroid fascia divided. Superior Laryngeal Nerve (SLN)
Fig. 4Capsular dissection with preservation of parathyroid tissue and ligation of superior pole vessels. a Identification of parathyroid glands while keeping the recurrent laryngeal nerve (RLN) under direct view; b Isolation and ligation of superior pole vessels; c Surgical bed after resection
Indications for surgery
| Total thyroidectomy | Hemi-thyroidectomy | Completion thyroidectomy | Total | |
|---|---|---|---|---|
| Nodules requiring diagnosis | ||||
| Intermediate suspicion for malignancy | – | 114 (54%) | 2 (5%) | 116 (34%) |
| High suspicion for malignancy | 15 (16%) | 2 (1%) | 1 (3%) | 18 (5%) |
| Thyromegaly | ||||
| Obstructive/Symptomatic | 20 (22%) | 73 (34%) | 6 (16%) | 99 (29%) |
| Substernal goiter | 5 (5%) | 8 (4%) | – | 14 (4%) |
| Malignancy | ||||
| Papillary carcinoma | 36 (40%) | 2 (1%) | 17 (45%) | 55 (16%) |
| Follicular carcinoma | – | – | 8 (21%) | 8 (2%) |
| Poorly differentiated carcinoma | – | – | 1 (3%) | 1 (0.3%) |
| Lymphoma | – | – | 1 (3%) | 1 (0.3%) |
| Endocrinological diseases | ||||
| Graves’ disease | 13 (14%) | 1 (0.5%) | 1 (3%) | 15 (4%) |
| Hashimoto thyroiditis | 1 (1%) | 2 (1%) | – | 3 (1%) |
| Other | ||||
| Symptomatic cyst | – | 9 (4%) | – | 9 (3%) |
| PET incidentaloma | 1 (1%) | 2 (1%) | – | 3 (1%) |
Pathological diagnoses
| Total thyroidectomy | Hemi-thyroidectomy | Completion thyroidectomy | Total | |
|---|---|---|---|---|
| Malignancies | ||||
| Papillary | 50 (54%) | 22 (10%) | 12 (32%) | 84 (25%) |
| Follicular | 1 (1%) | 11 (5%) | 2 (5%) | 14 (4%) |
| Poorly differentiated | 1 (1%) | 1 (0.5%) | – | 2 (1%) |
| B-Cell lymphoma | – | 1 (0.5%) | – | 1 (0.3%) |
| Renal cell carcinoma | 1 (1%) | – | – | 1 (0.3%) |
| Goiters | ||||
| Multinodular goiter | 16 (18%) | 73 (34%) | 9 (24%) | 98 (29%) |
| Diffuse goiter | 1 (1%) | 5 (2%) | 1 (3%) | 7 (2%) |
| Endocrine diseases | ||||
| Graves’ disease | 8 (9%) | 1 (0.5%) | – | 9 (3%) |
| Hashimoto’s thyroiditis | 7 (8%) | 10 (5%) | 1 (3%) | 18 (5%) |
| Other benign pathology | ||||
| Follicular adenoma | 4 (4%) | 65 (31%) | 1 (3%) | 70 (20%) |
| Thyroid cyst | – | 5 (2%) | – | 5 (2%) |
| Not otherwise specified | 2 (2%) | 19 (9%) | 12 (32%) | 33 (10%) |
Surgical times
| Total thyroidectomy | Hemi-thyroidectomy | Completion thyroidectomy | Total | |
|---|---|---|---|---|
| All indications | 48 min (40–60 min) | 39 min (33–47 min) | 40 min (25–93 min) | 41 min (35–51 min) |
| Nodules requiring diagnosis | 42 min (39–50 min) | 38 min (32–44 min) | 29 min (27–56 min) | 39 min (32–45 min) |
| Thyromegaly | ||||
| Obstructive/Symptomatic | 57 min (47–66 min) | 41 min (35–50 min) | 41 min (33–54 min) | 44 min (37–53 min) |
| Substernal goiter | 84 min (50–98 min) | 60 min (52–65 min) | 93 min | 64 min (51–81 min) |
| Malignancy | 47 min (40–53 min) | 51 min (45–55 min) | 39 min (36–46 min) | 43 min (38–51 min) |
| Graves’ disease | 55 min (43–63 min) | 60 min | 67 min | 56 min (43–65 min) |
Abbreviations: IQR interquartile range, min minutes
Course in hospital and complications
| Total thyroidectomy | Hemi–thyroidectomy | Completion thyroidectomy | Total | |
|---|---|---|---|---|
| Nights in hospital – median (Range) | 1 (0–30) | 0 (0–3) | 1 (1–7) | 1 (0 – 30) |
| Conversion to alternative approach – n (%) | 2 (2%) | – | 1 (3%) | 3 (1%) |
| Complications – n (%) | ||||
| Transient hypocalcemia | 16 (18%) | – | 1 (3%) | 17 (5%) |
| Permanent hypocalcemia | 1 (1%) | – | 2 (5%) | 3 (1%) |
| Temporary vocal cord paresis/Paralysis | 13 (14%) | 14 (7%) | 3 (8%) | 30 (9%) |
| Permanent vocal cord paresis/Paralysis | 1 (1%) | – | – | 1 (0.3%) |
| Hematoma | 1 (1%) | 4 (2%) | 1 (3%) | 6 (2%) |
| Seroma | – | 1 (0.5%) | – | |
| Wound infection | 5 (6%) | 3 (1%) | 1 (2.6%) | 9 (3%) |
| Subcutaneous emphysema | 1 (1%) | 2 (1%) | – | 3 (1%) |